https://www.selleckchem.com/pr....oducts/hsp990-nvp-hs
19). CONCLUSIONS Based on these findings, liraglutide should be considered suitable for patients with T2D with or without a history of NYHA functional class I to III HF. (Liraglutide Effect and Action in Diabetes Evaluation of Cardiovascular Outcome Results [LEADER]; NCT01179048). BACKGROUND Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for large central laboratory platforms. OBJECTIVES This study aimed to assess the clinical performance of a point-of-care (POC)-hs-cTnI assay in patients wi
Like
Comment
Share
